ClinicalTrials.Veeva

Menu

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

Organon logo

Organon

Status and phase

Completed
Phase 3

Conditions

Hypertension
Type 2 Diabetes Mellitus

Treatments

Drug: Comparator : ramipril /Duration of Treatment : 8 Weeks
Drug: MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks

Study type

Interventional

Funder types

Industry

Identifiers

NCT00480805
0954A-245
2007_554

Details and patient eligibility

About

A study to test the safety and efficacy of HYZAAR as compared to Ramipril in patients with type 2 diabetes mellitus (high blood sugar) and hypertension (high blood pressure).

Enrollment

312 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is at least 18 years old, has been diagnosed with type 2 diabetes mellitus

Exclusion criteria

  • Patient has renal disease, malignant hypertension, uncontrolled type 2 diabetes mellitus, history of stroke, TIA (Transient Ischemic Attacks) , or heart disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems